| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $5.0M | -42.6% |
| SG&A Expense | $10.7M | -10.4% |
| Operating Income | -$15.8M | -24.4% |
| Interest Expense | $22K | +41.5% |
| Net Income | -$15.8M | -8.0% |
| EPS (Basic) | -$47.88 | -128.0% |
| EPS (Diluted) | -$47.88 | -128.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.7M | +172.3% |
| Accounts Receivable | $93K | +0.0% |
| Current Assets | $5.0M | +45.2% |
| Total Assets | $6.9M | +26.5% |
| Current Liabilities | $3.1M | +26.2% |
| Total Liabilities | $3.3M | +21.6% |
| Stockholders' Equity | $3.6M | +31.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.4M | +44.6% |
| Investing Cash Flow | -$500K | — |
| Financing Cash Flow | $15.2M | -3.3% |